Literature DB >> 10203041

Detailed immunophenotype of CD8+ memory cytotoxic T-lymphocytes (CTL) against HIV-1 with respect to expression of CD45RA/RO, CD62L and CD28 antigens.

J V Giorgi1, M A Hausner, L E Hultin.   

Abstract

We have previously reported that circulating effector cytotoxic CD8+ T-lymphocytes (CTLs) against HIV-1 express CD38 and HLA-DR activation antigens. In this study, we performed two series of FACS sorts to phenotype and characterize precursors of CTL effectors. First we looked at memory CTL activity against HIV-1 stimulated by antigen as well as CTL activity stimulated by CD3 mAb with regard to whether the precursors expressed CD45RA and/or CD62L. We found that the precursor cells that could be stimulated with antigen to become effectors within 7 days predominated in the CD45RA CD62L subset. However. in donors with low levels of CD8+ T-cell activation as measured by CD38 antigen expression, memory cells could also be found in the CD45RA+ CD62L+ subset. Our data indicate that reversion of memory cells to the CD45RA+ CD62L+ phenotype can occur in humans, especially in donors with low levels of virus replication and minimal CD8 + T-cell activation. Next, we looked at CD28 expression with regard to antigen specific memory cells and again found that the level of virus replication and CD8+ T-cell activation influenced the subset that contained the memory cells. In donors with high levels of virus replication, our results indicated that CTL were being actively recruited from both CD28+ and CD28 subsets, while in donors with undetectable levels of viral replication, the memory cells were entirely in the CD28 compartment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203041     DOI: 10.1016/s0165-2478(98)00170-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Neural networks morbidity and mortality modeling during loss of HIV T-cell homeostasis.

Authors:  G E Hatzakis; C M Tsoukas
Journal:  Proc AMIA Symp       Date:  2002

2.  Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.

Authors:  Udo Hoffmann; Michael T Lu; Devvora Olalere; Elizabeth C Adami; Michael T Osborne; Alex Ivanov; John Sukumar Aluru; Saeyun Lee; Nadja Arifovic; Edgar Turner Overton; Carl J Fichtenbaum; Judith A Aberg; Beverly Alston-Smith; Karin L Klingman; Myron Waclawiw; Tricia H Burdo; Kenneth C Williams; Markella V Zanni; Patrice Desvigne-Nickens; Katharine Cooper-Arnold; Kathleen V Fitch; Heather Ribaudo; Pamela S Douglas; Steven K Grinspoon
Journal:  Am Heart J       Date:  2019-03-04       Impact factor: 4.749

Review 3.  Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.

Authors:  Alberto Cagigi; Nicola Cotugno; Carlo Giaquinto; Luciana Nicolosi; Stefania Bernardi; Paolo Rossi; Iyadh Douagi; Paolo Palma
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

4.  Memories of John Fahey and His Contributions to the Multicenter AIDS Cohort Study (MACS).

Authors:  John Phair; Roger Detels; Joseph Margolick; Charles Rinaldo; Lisa Jacobson; Otoniel Martínez-Maza; Steven Wolinsky; Alvaro Muñoz
Journal:  For Immunopathol Dis Therap       Date:  2015

5.  Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women.

Authors:  Uma Shanmugasundaram; J William Critchfield; Jane Pannell; Jean Perry; Linda C Giudice; Karen Smith-McCune; Ruth M Greenblatt; Barbara L Shacklett
Journal:  Am J Reprod Immunol       Date:  2013-12-06       Impact factor: 3.886

6.  Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections?

Authors:  Samuel Nyamweya; John Townend; Akram Zaman; Sarah Jane Steele; David Jeffries; Sarah Rowland-Jones; Hilton Whittle; Katie L Flanagan; Assan Jaye
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

7.  Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.

Authors:  Ali Sakhdari; Shariq Mujib; Bahareh Vali; Feng Yun Yue; Sonya MacParland; Kiera Clayton; Richard Bradley Jones; Jun Liu; Erika Yue Lee; Erika Benko; Colin Kovacs; Jennifer Gommerman; Rupert Kaul; Mario A Ostrowski
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

8.  Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.

Authors:  O Brain; A M Menzies; A D Kelleher; S C Sasson; J J Zaunders; K Nahar; C M L Munier; B P Fairfax; A Olsson-Brown; C Jolly; S A Read; G Ahlenstiel; U Palendira; R A Scolyer; M S Carlino; M J Payne; V T F Cheung; T Gupta; P Klenerman; G V Long
Journal:  Clin Exp Immunol       Date:  2020-08-19       Impact factor: 5.732

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.